Targeting of EZH2 inhibits epithelial‑mesenchymal transition in head and neck squamous cell carcinoma via regulating the STAT3/VEGFR2 axis
Minghui Zhao(Sunnybrook Health Science Centre), Xuan Zhou(Tianjin Medical University Cancer Institute and Hospital)
Cited by 31
Related Papers
Downregulation of miR-21 inhibits EGFR pathway and suppresses the growth of human glioblastoma cells independent of PTEN status
|Laboratory Investigation|2010|362
PD-L2 glycosylation promotes immune evasion and predicts anti-EGFR efficacy
|Journal for ImmunoTherapy of Cancer|2021|85
WP1066 Sensitizes Oral Squamous Cell Carcinoma Cells to Cisplatin by Targeting STAT3/miR-21 axis
|Scientific Reports|2014|53
Targeting EZH2 regulates tumor growth and apoptosis through modulating mitochondria dependent cell-death pathway in HNSCC
|Oncotarget|2015|47
Role of the EZH2/miR-200 axis in STAT3-mediated OSCC invasion
|International Journal of Oncology|2018|42